SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (977)6/18/1999 1:39:00 PM
From: scaram(o)uche   of 1073
 
"Fidelity's shareholders paid 1.5% in expenses last year; Franklin's
paid 1.47%. However, the 5.75% sales charge for Franklin's class-A
shares is much higher than Fidelity's front-end fee of 3%."

morningstar.net


Fidelity Select
Biotechnology
Franklin Biotech
Discovery

YTD Return
9.08%
-5.3%

1-year Return
28.16%
-3.3%

3-year Return
18.56%
N/A

Category Risk
Avg
NA

Data through 3-31-99
*****************************

Everyone who wants to pay Kurt 5.75% to let him manage your money,
please raise your hand. I have some land in Florida.......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News